Taylor Chartier ^UDM

Taylor Chartier, CEO of Modicus Prime, brings a wealth of experience as a former data scientist and engineer in the pharmaceutical industry. With a background in chemical engineering and ongoing pursuit of a Ph.D. in applied AI with a focus on wearables research for Parkinson's patients, Chartier has a deep understanding of the industry's challenges in maintaining product quality. Recognizing the potential of AI in process development and drug manufacturing, she founded Modicus Prime. The company provides AI computational techniques to enhance drug production efficiency and safety. Modicus Prime's proprietary GxP-compliant software, mpVision, automates biologics image analysis, offering real-time classification of imaging data for quality control across R&D and manufacturing. Backed by venture funding and strategic Partnersships with industry leaders, Modicus Prime addresses unmet needs in the Life Sciences industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs. The company's innovative Self-Service AI solution, mpVision, places cutting-edge AI capabilities in the hands of biotechnology experts, contributing to the elimination of contamination and ensuring the highest standards in pharmaceutical manufacturing.